scholarly journals Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment

2012 ◽  
Vol 110 (3) ◽  
pp. 305-313 ◽  
Author(s):  
Rintaro Hashizume ◽  
Ivan Smirnov ◽  
Sharon Liu ◽  
Joanna J. Phillips ◽  
Jeanette Hyer ◽  
...  
BMC Cancer ◽  
2008 ◽  
Vol 8 (1) ◽  
Author(s):  
Camila ML Machado ◽  
Rafael Y Ikemori ◽  
Tatiana Q Zorzeto ◽  
Ana CMA Nogueira ◽  
Suse DS Barbosa ◽  
...  

2021 ◽  
Author(s):  
Yunfei Liao ◽  
Zaili Luo ◽  
Yaqi Deng ◽  
Feng Zhang ◽  
Rohit Rao ◽  
...  

Abstract Background Diffuse intrinsic pontine glioma (DIPG) is a pediatric lethal high-grade brainstem glioma with no effective therapies. OLIG2 was reported to be critical for the growth of a DIPG cell line CCHMC-DIPG-1. Surprisingly, we found that the CCHMC-DIPG-1 cells express little OLIG2 and exhibit a mesenchymal phenotype, which raised a question regarding the role of OLIG2 in the growth of DIPG cells. Methods We evaluated the function of OLIG2 in different DIPG cell lines through molecular and genetic approaches and performed transcriptomic and genomic landscape profiling including whole-genome bisulfite-sequencing, RNA-seq, ATAC-seq, and ChIP-seq. shRNA-mediated knockdown and CRISPR-Cas9-mediated knockout approaches were utilized to assess OLIG2 functions in DIPG cell growth. Results We found that DIPG cells are phenotypically heterogeneous and exhibit the characteristics of distinct malignant gliomas including proneural, classical, and mesenchymal subtypes. OLIG2 knockdown did not impact the growth of CCHMC-DIPG-1 cells, wherein OLIG2 is epigenetically silenced. Moreover, OLIG2 deletion did not substantially impair OLIG2-expressing proneural-like DIPG growth but led to an upregulation of HIPPO-YAP1 and EGFR signaling and a tumor phenotype shift. Targeting HIPPO-YAP1 and EGFR signaling in OLIG2-deficient DIPG cells inhibited tumor cell growth. Conclusions Our data indicate that OLIG2 is dispensable for DIPG growth but regulates the phenotypic switch of DIPG tumor cells. OLIG2 downregulation leads to deregulation of adaptive YAP1 and EGFR signaling. Targeting YAP1 and EGFR pathways inhibits the growth of OLIG2-deficient DIPG cells, pointing to a therapeutic potential by targeting adaptive signaling to treat DIPG tumors with nominal OLIG2 expression.


2015 ◽  
Vol 25 (4) ◽  
pp. 753-757 ◽  
Author(s):  
Subhadeep Banerjee ◽  
Anjan Chattopadhyay ◽  
Arnab Banerjee ◽  
Meera Haridas ◽  
Praveen Saini ◽  
...  

2009 ◽  
Vol 72 (4) ◽  
pp. 310-316 ◽  
Author(s):  
Camila Maria Longo Machado ◽  
Tatiane Queiroz Zorzeto ◽  
Juares E. Romero Bianco ◽  
Renata Giardini Rosa ◽  
Selma Candelaria Genari ◽  
...  

FEBS Letters ◽  
1986 ◽  
Vol 201 (1) ◽  
pp. 109-113 ◽  
Author(s):  
J.-E. Månsson ◽  
P. Fredman ◽  
D.D. Bigner ◽  
K. Molin ◽  
B. Rosengren ◽  
...  

1998 ◽  
Vol 1380 (3) ◽  
pp. 377-388 ◽  
Author(s):  
Tomas Asplund ◽  
Jonas Brinck ◽  
Masanobu Suzuki ◽  
Michael J Briskin ◽  
Paraskevi Heldin

1981 ◽  
Vol 53 (1) ◽  
pp. 21-28 ◽  
Author(s):  
A. C. Diserens ◽  
N. de Tribolet ◽  
A. Martin-Achard ◽  
A. C. Gaide ◽  
J. F. Schnegg ◽  
...  

1992 ◽  
Vol 28 (9-10) ◽  
pp. 609-614 ◽  
Author(s):  
Carol A. Kruse ◽  
Dawn H. Mitchell ◽  
Bette K. Kleinschmidt-DeMasters ◽  
Wilbur A. Franklin ◽  
Helvise G. Morse ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document